Find an Alzheimer's clinical trial

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Search title, drug, condition or sponsor

Recruiting

Exact registry status

Phase

Intervention class

Study type

Country

Results per page

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,351–7,375 of 7,816 matching trials · page 295 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial	Phase	Status	Enrolled	Sponsor	Last updated
Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163 NCT01454115 BMS-708163 (Gamma-Secretase Inhibitor); BMS-708163 (Gamma-Secretase...	PHASE1 other	COMPLETED	116	Bristol-Myers Squibb INDUSTRY	2011-11-21
Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency) NCT01475578 STA-1; Ergoloid Mesylates tablet Runs in: China · 5 sites	PHASE2 other	COMPLETED	240	Sinphar Pharmaceutical Co., Ltd OTHER	2011-11-21
Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia NCT00099216 Rivastigmine Runs in: Austria; Canada; France; Germany; Italy; Russia; Spain; S... · 63 sites	PHASE3 symptomatic-cholinergic	COMPLETED	708	Novartis Pharmaceuticals INDUSTRY	2011-11-17
Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment NCT00234637 Rivastigmine, memantine Runs in: France · 1 site	PHASE4 symptomatic-cholinergic	COMPLETED	204	Novartis INDUSTRY	2011-11-17
Effects of Community Occupational Therapy in Older Patients With Dementia and Their Caregivers. NCT00295152 community occupational therapy in dementia Runs in: Netherlands · 1 site	NA other	UNKNOWN	135	Radboud University Medical Center OTHER	2011-11-17
The Dementia Study in Northern Norway NCT00443014 Cognitive, physical and social stimulation Runs in: Norway · 1 site	PHASE4 other	COMPLETED	187	University Hospital of North Norway OTHER	2011-11-10
Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity NCT01466543 Zydena (Udenafil); Placebo Runs in: South Korea · 1 site	PHASE2 other	UNKNOWN	80	Samsung Medical Center OTHER	2011-11-08
Memantine - Communication Study NCT00624026 Memantine-HCl Runs in: Germany · 1 site	PHASE3 symptomatic-cholinergic	COMPLETED	107	Merz Pharmaceuticals GmbH INDUSTRY	2011-11-01
Rivastigmine in Mild Alzheimer's Disease, FMRI Study NCT00627848 rivastigmine Runs in: Finland · 1 site	NA symptomatic-cholinergic	COMPLETED	20	Kuopio University Hospital OTHER	2011-10-28
Life From Vision in Alzheimer Disease NCT00838942 Questionaries Runs in: France · 1 site	NA other	COMPLETED	80	Assistance Publique - Hôpitaux de Paris OTHER	2011-10-28
Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls NCT01147679 Runs in: United States · 1 site	NA other	UNKNOWN	99	University of California, Los Angeles OTHER	2011-10-28
A Study to Compare Genetic Variations of IGF-I and IGF-II NCT01329523 Runs in: United States · 1 site	NA other	COMPLETED	50	Avera McKennan Hospital & University Health Center OTHER	2011-10-06
The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease NCT01329536 Runs in: United States · 1 site	NA other	COMPLETED	50	Avera McKennan Hospital & University Health Center OTHER	2011-10-06
Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE) NCT00867828 Neptune Krill Oil; Fish Oil; Placebo (soy oil) Runs in: Canada · 14 sites	PHASE4 other	COMPLETED	175	NeuroBioPharm Inc. INDUSTRY	2011-10-03
Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) NCT00908999 Runs in: United States · 1 site	NA other	COMPLETED	60	University of Wisconsin, Madison OTHER	2011-09-29
Memantine and Antipsychotics Use NCT00649220 Memantine Runs in: Germany · 1 site	PHASE4 symptomatic-cholinergic	TERMINATED	19	Merz Pharmaceuticals GmbH INDUSTRY	2011-09-26
The Effect of Intravenous Fentanyl Prior the End of Surgery on Emergence Agitation in Paediatric Patients After General Anesthesia NCT01440114 fentanyl; NSS Runs in: Thailand · 1 site	NA other	COMPLETED	144	Prince of Songkla University OTHER	2011-09-26
Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea NCT01019473 AFQ056; Placebo Runs in: Germany; United Kingdom · 10 sites	PHASE2 other	TERMINATED	44	Novartis Pharmaceuticals INDUSTRY	2011-09-23
Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia NCT01436552 Runs in: France · 1 site	NA other	UNKNOWN	392	Centre Hospitalier Esquirol OTHER	2011-09-19
Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease NCT00753662 1Hz TMS with H2 coil; 10Hz TMS with H2 coil to prefrontal and parie... Runs in: Israel · 1 site	PHASE2 other	UNKNOWN	45	Tel-Aviv Sourasky Medical Center OTHER_GOV	2011-09-13
Early Detection of Mild Cognitive Impairment in Individual Patients NCT00243451 PET scan & fMRI Runs in: United States · 1 site	NA other	COMPLETED	34	Louisiana State University Health Sciences Center Shreveport OTHER	2011-09-07
A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study NCT00809510 ABT-089 Runs in: United States · 22 sites	PHASE2 other	TERMINATED	63	Abbott INDUSTRY	2011-09-02
Effective Strategies for Dementia Care NCT00653731 Snoezelen ©; structured reminiscence therapy; 10-minutes activation... Runs in: Germany · 1 site	NA other	COMPLETED	327	Martin-Luther-Universität Halle-Wittenberg OTHER	2011-08-31
Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease NCT00555204 ABT-089; ABT-089; ABT-089; ABT-089; ABT-089; ABT-089; placebo Runs in: United States · 42 sites	PHASE2 other	TERMINATED	337	Abbott INDUSTRY	2011-08-23
Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease NCT00965588 UB 311 Runs in: Taiwan · 2 sites	PHASE1 other	COMPLETED	19	United Biomedical INDUSTRY	2011-08-23

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry: ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file: 7,816
Source file: trials.csv (3.8 MB, 7816 rows)
Basis: Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024 · score 88/100
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial The Lancet. Neurology, 2026 · score 86/100
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial Lancet (London, England), 2021 · score 86/100
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease Journal of Alzheimer's disease : JAD, 2026 · score 86/100
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial EBioMedicine, 2024 · score 85/100

All 162 studies on Clinical trials →